-
Product Insights
Erectile Dysfunction – Drugs In Development, 2023
Global Markets Direct’s, ‘Erectile Dysfunction - Drugs In Development, 2023’, provides an overview of the Erectile Dysfunction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Erectile Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Company Profile
Acerus Pharmaceuticals Corp – Company Profile
Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets, and distributes novel innovative branded products. It focuses in the therapeutic areas of women’s health (female sexual dysfunction, hormone replacement therapy) and men’s health (urology). The company’s marketed products include Estrace, for menopausal symptom,s and Natesto, testosterone for male hypogonadism. Acerus pipeline products include Tefina, Avanafil, Elegant and Lidbree indicated for various health issues related to men and women. The company sells products through its salesforce in Canada and...
Add to Basket -
Product Insights
Male Hypogonadism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, a decrease in muscle mass, and loss of bone mass (osteoporosis). Risk factors for hypogonadism include HIV/AIDS, Klinefelter syndrome, Kallmann syndrome, injury to testicles, and untreated sleep apnea. Treatment includes hormone replacement. The Male Hypogonadism drugs in development market research report provide comprehensive information on the therapeutics under development for Male Hypogonadism, complete with analysis by stage of development, drug target,...
-
Product Insights
Male Hypogonadism – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Male Hypogonadism - Global Clinical Trials Review, H2, 2021" provides an overview of Male Hypogonadism Clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Male Hypogonadism Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, H2, 2020" provides an overview of Male Hypogonadism Clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Male Hypogonadism Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, H1, 2018" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Male Hypogonadism Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, H2, 2016" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Male Hypogonadism Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, H1, 2016" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...